Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins

W E Sanders1, C C Sanders

  • 1Departments of Medical Microbiology and Medicine, Creighton University School of Medicine, Omaha, Nebraska 68178-0213.

Insights

Antibiotic resistance to beta-lactam drugs is a growing concern in hospitals. This resistance, often missed by standard tests, leads to treatment failures in patients with specific bacterial infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Beta-lactam antibiotics are crucial for treating bacterial infections.
  • Inducible beta-lactamases are enzymes produced by certain bacteria that confer resistance to beta-lactam antibiotics.
  • Emergence of multidrug resistance is a significant challenge in clinical settings.

Observation:

  • Resistance to newer cephalosporins has emerged in 14%-56% of patients infected with organisms producing inducible beta-lactamases.
  • This resistance is linked to clinical failure or relapse in 25%-75% of cases.
  • Widespread use of newer cephalosporins correlates with the spread of multidrug-resistant organisms in hospitals.

Findings:

  • Combination therapy shows limited impact on resistance rates or clinical outcomes.
  • Standard susceptibility testing may fail to detect inducible beta-lactamase-mediated resistance.
  • Calculation methods for resistance rates can underestimate the problem's true magnitude.

Implications:

  • Clinical management of infections caused by inducible beta-lactamase-producing organisms requires careful consideration of antibiotic resistance.
  • Improved diagnostic methods are needed to accurately detect resistance.
  • Strategies to curb the spread of multidrug-resistant bacteria are essential, especially in hospital environments.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...